Literature DB >> 28809602

Fertility Preservation and Sexual Health After Cancer Therapy.

Nigel Pereira1, Glenn L Schattman1.   

Abstract

Recent developments in cancer diagnostics and treatments have considerably improved long-term survival rates. Despite improvements in chemotherapy regimens, more focused radiotherapy and diverse surgical options, cancer treatments often have gonadotoxic side-effects that can manifest as loss of fertility or sexual dysfunction, particularly in young cancer survivors. In this review, we focus on two pertinent quality-of-life issues in female cancer survivors of reproductive age-fertility preservation and sexual function. Fertility preservation encompasses all clinical and laboratory efforts to preserve a woman's chance to achieve future genetic motherhood. These efforts range from well-established protocols such as ovarian stimulation with cryopreservation of embryos or oocytes, to nascent clinical trials involving cryopreservation and re-implantation of ovarian tissue. Therefore, fertility preservation strategies are individualized to the cancer diagnosis, time interval until initiation of treatments must begin, prognosis, pubertal status, and maturity level of patient. Some patients choose not to pursue fertility preservation, and the conversation then centers around other quality of life issues. Not all cancer treatments cause loss of fertility; however, most treatments can directly impact the physical and psychosocial aspects of sexual function. Cancer treatment is also associated with fear, anxiety, and depression, which can further decrease sexual desire, function, and frequency. Sexual dysfunction after cancer treatment is generally ascertained by compassionate inquiry. Strategies to promote sexual function after cancer treatment include pelvic floor exercises, clitoral therapy devices, pharmacologic agents, as well as couples-based psychotherapeutic and psycho-educational interventions. Quality-of-life issues in young cancer survivors are often best addressed by utilizing a multidisciplinary team consisting of physicians, nurses, social workers, psychiatrists, sex educators, counselors, or therapists.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28809602     DOI: 10.1200/JOP.2017.023705

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN: 1554-7477            Impact factor:   3.840


  6 in total

Review 1.  Oncofertility-An emerging discipline rather than a special consideration.

Authors:  Antoinette Anazodo; Lauren Ataman-Millhouse; Yasmin Jayasinghe; Teresa K Woodruff
Journal:  Pediatr Blood Cancer       Date:  2018-07-03       Impact factor: 3.167

2.  Management of Primary Ovarian Insufficiency Symptoms in Survivors of Childhood and Adolescent Cancer.

Authors:  Emma Gargus; Rebecca Deans; Antoinette Anazodo; Teresa K Woodruff
Journal:  J Natl Compr Canc Netw       Date:  2018-09       Impact factor: 11.908

3.  Decellularization and recellularization of the ovary for bioengineering applications; studies in the mouse.

Authors:  Ahmed Baker Alshaikh; Arvind Manikantan Padma; Matilda Dehlin; Randa Akouri; Min Jong Song; Mats Brännström; Mats Hellström
Journal:  Reprod Biol Endocrinol       Date:  2020-07-23       Impact factor: 5.211

4.  Establishing a nonlethal and efficient mouse model of male gonadotoxicity by intraperitoneal busulfan injection.

Authors:  Yun Xie; Cun-Can Deng; Bin Ouyang; Lin-Yan Lv; Jia-Hui Yao; Chi Zhang; Hai-Cheng Chen; Xiao-Yan Li; Xiang-Zhou Sun; Chun-Hua Deng; Gui-Hua Liu
Journal:  Asian J Androl       Date:  2020 Mar-Apr       Impact factor: 3.285

5.  Medical egg freezing: How cost and lack of insurance cover impact women and their families.

Authors:  Marcia C Inhorn; Daphna Birenbaum-Carmeli; Lynn M Westphal; Joseph Doyle; Norbert Gleicher; Dror Meirow; Hila Raanani; Martha Dirnfeld; Pasquale Patrizio
Journal:  Reprod Biomed Soc Online       Date:  2018-02-04

6.  Pediatric oncology clinician communication about sexual health with adolescents and young adults: A report from the children's oncology group.

Authors:  Natasha N Frederick; Kristin Bingen; Sharon L Bober; Brooke Cherven; Xinxin Xu; Gwendolyn P Quinn; Lingyun Ji; David R Freyer
Journal:  Cancer Med       Date:  2021-06-15       Impact factor: 4.452

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.